# Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

> **NCT07040592** · PHASE2 · RECRUITING · sponsor: **Yale University** · enrollment: 30 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)
- HIV

## Interventions

- **DRUG:** semaglutide

## Key facts

- **NCT ID:** NCT07040592
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040592, "Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07040592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*